X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2019 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Dr. Reddys with Abbott India - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

DR. REDDYS LAB vs ABBOTT INDIA - Comparison Results

DR. REDDYS LAB     Change

Dr. Reddy's is a leading pharmaceutical company in the country with presence across the value chain. While the global generics business accounted for 69% of total revenues in FY12, the PSAI business (Pharma Services and Active Ingredients - PSAI) con... More

ABBOTT INDIA 
   Change

Formerly known as Knoll Pharmaceuticals Limited, Abbott India Limited (AIL) is a subsidiary of Abbott Capital India Limited in which the latter holds about 69% stake. It is involved in the discovery, development, manufacture and marketing of pharmace... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    DR. REDDYS LAB ABBOTT INDIA DR. REDDYS LAB/
ABBOTT INDIA
 
P/E (TTM) x 22.6 40.4 55.9% View Chart
P/BV x 3.1 10.8 28.7% View Chart
Dividend Yield % 0.8 0.6 119.3%  

Financials

 DR. REDDYS LAB   ABBOTT INDIA
EQUITY SHARE DATA
    DR. REDDYS LAB
Mar-19
ABBOTT INDIA
Mar-18
DR. REDDYS LAB/
ABBOTT INDIA
5-Yr Chart
Click to enlarge
High Rs2,8756,110 47.1%   
Low Rs1,8883,996 47.2%   
Sales per share (Unadj.) Rs930.21,552.2 59.9%  
Earnings per share (Unadj.) Rs117.4188.8 62.2%  
Cash flow per share (Unadj.) Rs185.8196.4 94.6%  
Dividends per share (Unadj.) Rs20.0055.00 36.4%  
Dividend yield (eoy) %0.81.1 77.2%  
Book value per share (Unadj.) Rs844.4796.6 106.0%  
Shares outstanding (eoy) m166.0721.25 781.5%   
Bonus/Rights/Conversions ESOP--  
Price / Sales ratio x2.63.3 78.6%   
Avg P/E ratio x20.326.8 75.8%  
P/CF ratio (eoy) x12.825.7 49.8%  
Price / Book Value ratio x2.86.3 44.5%  
Dividend payout %17.029.1 58.5%   
Avg Mkt Cap Rs m395,496107,376 368.3%   
No. of employees `00022.03.3 661.2%   
Total wages/salary Rs m33,5623,937 852.5%   
Avg. sales/employee Rs Th7,032.89,929.3 70.8%   
Avg. wages/employee Rs Th1,527.91,185.1 128.9%   
Avg. net profit/employee Rs Th887.71,207.7 73.5%   
INCOME DATA
Net Sales Rs m154,48232,985 468.3%  
Other income Rs m3,3751,170 288.5%   
Total revenues Rs m157,85734,155 462.2%   
Gross profit Rs m31,7825,245 605.9%  
Depreciation Rs m11,348162 7,009.3%   
Interest Rs m88938 2,327.2%   
Profit before tax Rs m22,9206,215 368.8%   
Minority Interest Rs m00-   
Prior Period Items Rs m4380-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m3,8582,203 175.1%   
Profit after tax Rs m19,5004,012 486.0%  
Gross profit margin %20.615.9 129.4%  
Effective tax rate %16.835.4 47.5%   
Net profit margin %12.612.2 103.8%  
BALANCE SHEET DATA
Current assets Rs m111,10122,655 490.4%   
Current liabilities Rs m58,9736,681 882.7%   
Net working cap to sales %33.748.4 69.7%  
Current ratio x1.93.4 55.6%  
Inventory Days Days7965 122.5%  
Debtors Days Days9429 323.1%  
Net fixed assets Rs m101,245835 12,118.3%   
Share capital Rs m830213 390.6%   
"Free" reserves Rs m139,40616,715 834.0%   
Net worth Rs m140,23616,928 828.4%   
Long term debt Rs m22,0000-   
Total assets Rs m224,65624,162 929.8%  
Interest coverage x26.8163.7 16.4%   
Debt to equity ratio x0.20-  
Sales to assets ratio x0.71.4 50.4%   
Return on assets %9.116.8 54.1%  
Return on equity %13.923.7 58.7%  
Return on capital %14.936.9 40.5%  
Exports to sales %00-   
Imports to sales %00-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m88,673369 24,060.6%   
Fx outflow Rs m19,1043,807 501.9%   
Net fx Rs m69,569-3,438 -2,023.5%   
CASH FLOW
From Operations Rs m28,7041,527 1,879.8%  
From Investments Rs m-7,727-2,148 359.7%  
From Financial Activity Rs m-21,326-1,024 2,082.0%  
Net Cashflow Rs m-314-1,646 19.1%  

Share Holding

Indian Promoters % 25.5 0.0 -  
Foreign collaborators % 0.0 75.0 -  
Indian inst/Mut Fund % 5.4 7.9 68.4%  
FIIs % 35.3 0.1 35,300.0%  
ADR/GDR % 18.5 0.0 -  
Free float % 15.3 17.1 89.5%  
Shareholders   75,885 18,270 415.4%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare DR. REDDYS LAB With:   DR. DATSONS LABS  STRIDES PHARMA SCIENCE  FDC LTD.  JUBILANT LIFE SCIENCES  BIOCON   

Compare DR. REDDYS LAB With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Yes Bank's Road Ahead(Podcast)

The stock markets witnessed selling pressure in the week gone by. Market participants remained cautious tracking tepid quarterly earnings amid weak cues.

Related Views on News

ABBOTT INDIA Announces Quarterly Results (4QFY19); Net Profit Up 13.1% (Quarterly Result Update)

May 28, 2019 | Updated on May 28, 2019

For the quarter ended March 2019, ABBOTT INDIA has posted a net profit of Rs 1 bn (up 13.1% YoY). Sales on the other hand came in at Rs 9 bn (up 15.0% YoY). Read on for a complete analysis of ABBOTT INDIA's quarterly results.

ABBOTT INDIA Announces Quarterly Results (3QFY19); Net Profit Up 1.4% (Quarterly Result Update)

Feb 12, 2019 | Updated on Feb 12, 2019

For the quarter ended December 2018, ABBOTT INDIA has posted a net profit of Rs 1 bn (up 1.4% YoY). Sales on the other hand came in at Rs 9 bn (up 7.5% YoY). Read on for a complete analysis of ABBOTT INDIA's quarterly results.

DR. REDDYS LAB Announces Quarterly Results (3QFY19); Net Profit Up 67.0% (Quarterly Result Update)

Feb 4, 2019 | Updated on Feb 4, 2019

For the quarter ended December 2018, DR. REDDYS LAB has posted a net profit of Rs 5 bn (up 67.0% YoY). Sales on the other hand came in at Rs 39 bn (up 0.8% YoY). Read on for a complete analysis of DR. REDDYS LAB's quarterly results.

ABBOTT INDIA Announces Quarterly Results (2QFY19); Net Profit Up 0.1% (Quarterly Result Update)

Nov 14, 2018 | Updated on Nov 14, 2018

For the quarter ended September 2018, ABBOTT INDIA has posted a net profit of Rs 1 bn (up 0.1% YoY). Sales on the other hand came in at Rs 10 bn (up 5.2% YoY). Read on for a complete analysis of ABBOTT INDIA's quarterly results.

ABBOTT INDIA Announces Quarterly Results (1QFY19); Net Profit Up 70.8% (Quarterly Result Update)

Aug 20, 2018 | Updated on Aug 20, 2018

For the quarter ended June 2018, ABBOTT INDIA has posted a net profit of Rs 824 m (up 70.8% YoY). Sales on the other hand came in at Rs 8 bn (up 18.2% YoY). Read on for a complete analysis of ABBOTT INDIA's quarterly results.

More Views on News

Most Popular

These 3 Smallcap Stocks are Set to Make the Most of Smallcap Rebound(Profit Hunter)

Jul 9, 2019

As the sense of normalcy returns to the markets, the rebound in the quality smallcaps could be huge.

2 Stocks from Super Investor Sanjay Bakshi's Portfolio You Can Bet On...(The 5 Minute Wrapup)

Jul 12, 2019

Despite the current fear prevailing in the markets, both these stocks have the potential to deliver in 4-5 years.

After Disappointing Budget, Here's a Document that Concerns Largecap and Smallcap Investors(The 5 Minute Wrapup)

Jul 8, 2019

A new 'definition' of the stock universe that triggered the smallcap sell-off is back with the latest list...

The Electric Vehicle Disruption is Great News for this Smallcap Stock(Profit Hunter)

Jul 15, 2019

While big auto makers are finding the transition difficult and crying foul, this small cap company is already leading and benefitting from the electric vehicle disruption in the auto sector.

Budget an Icing on the Cake for This Smart Money Backed Affordable Housing Stock(The 5 Minute Wrapup)

Jul 10, 2019

Affordable housing is one of the most straightforward growth stories in India. This will help the real estate sector to come out of the slump.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2019
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

DR. REDDYS LAB SHARE PRICE


Jul 19, 2019 (Close)

TRACK DR. REDDYS LAB

  • Track your investment in DR. REDDYS LAB with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

DR. REDDYS LAB 5-YR ANALYSIS

COMPARE DR. REDDYS LAB WITH

MARKET STATS